Scott D. McGrew

FDA investigator

Appears on 4 documents from 2025 to 2026, mostly at sites in Indiana. Most often cites control of microbiological contamination (21 CFR 211.113).

4
Documents on file
4.5
Observations per 483
2025
First seen
2026
Most recent

What they cite most

From 18 observations

Activity by year

2025: 3, 2026: 1

Where

Indiana 2 · California 1 · Missouri 1

Often inspects with

Muna Algharibeh· Elvis Patel· Junho Pak

Is Scott D. McGrew coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 RayzeBio, Inc.Feb 24, 2026 · Indianapolis, Indiana
483 Eli Lilly and CompanyMay 20, 2025 · Indianapolis, Indiana
483 PCI San Diego, Inc.May 9, 2025 · San Diego, California
483 Sigma-Aldrich Manufacturing LLCApr 28, 2025 · Saint Louis, Missouri

About this profile

What does Scott D. McGrew inspect?

Scott D. McGrew appears on 4 documents on file covering 4 sites, mostly in Indiana.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.160 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Scott D. McGrew is dated Feb 24, 2026.

FDA Investigator Scott D. McGrew: 483s & Inspections · FDA Intel